» Articles » PMID: 34405711

Nomogram for Predicting Cancer-specific Survival in Undifferentiated Pleomorphic Sarcoma: A Surveillance, Epidemiology, and End Results -based Study

Overview
Journal Cancer Control
Specialty Oncology
Date 2021 Aug 18
PMID 34405711
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The purpose of this study was to construct and validate a nomogram for predicting cancer-specific survival (CSS) in undifferentiated pleomorphic sarcoma (UPS) patients at 3, 5, and 8 years after the diagnosis.

Methods: Data for UPS patients were extracted from the SEER (Surveillance, Epidemiology, and End Results) database. The patients were randomly divided into a training cohort (70%) and a validation cohort (30%). The backward stepwise Cox regression model was used to select independent prognostic factors. All of the factors were integrated into the nomogram to predict the CSS rates in UPS patients at 3, 5, and 8 years after the diagnosis. The nomogram' s performance was then validated using multiple indicators, including the area under the time-dependent receiver operating characteristic curve (AUC), consistency index (C-index), calibration curve, decision-curve analysis (DCA), integrated discrimination improvement (IDI), and net reclassification improvement (NRI).

Results: This study included 2,009 UPS patients. Ten prognostic factors were identified after analysis of the Cox regression model in the training cohort, which were year of diagnosis, age, race, primary site, histological grade, T, N, M stage, surgery status, and insurance status. The nomogram was then constructed and validated internally and externally. The relatively high C-indexes and AUC values indicated that the nomogram has good discrimination ability. The calibration curves revealed that the nomogram was well calibrated. NRI and IDI values were both improved, indicating that our nomogram was superior to the AJCC (American Joint Committee on Cancer) system. DCA curves demonstrated that the nomogram was clinically useful.

Conclusions: The first nomogram for predicting the prognosis of UPS patients has been constructed and validated. Its usability and performance showed that the nomogram can be applied to clinical practice. However, further external validation is still needed.

Citing Articles

Undifferentiated pleomorphic sarcoma of the adrenal gland: a case report and literature review.

Xiaochuan G, Wei Z, Chaoyong Y, Yu Z, Huayong J, Na Y Front Oncol. 2024; 14:1439357.

PMID: 39624627 PMC: 11609073. DOI: 10.3389/fonc.2024.1439357.


Development and validation of a machine learning-based model to predict postoperative overall survival in patients with soft tissue sarcoma: a retrospective cohort study.

Liu X, Yuan J, Wang X, Yu S Am J Cancer Res. 2024; 14(10):4731-4746.

PMID: 39553229 PMC: 11560808. DOI: 10.62347/ZQVY3877.


Incidence of Undifferentiated Pleomorphic Sarcoma (UPS) in the United States.

Ma J, Groisberg R, Shao C, Zhong W Sarcoma. 2024; 2024:6735002.

PMID: 39502684 PMC: 11537747. DOI: 10.1155/2024/6735002.


A Detailed Examination of Retroperitoneal Undifferentiated Pleomorphic Sarcoma: A Case Report and Review of the Existing Literature.

Balovic G, Stojanovic B, Radovanovic D, Lazic D, Ilic M, Jovanovic I J Clin Med. 2024; 13(13).

PMID: 38999251 PMC: 11242107. DOI: 10.3390/jcm13133684.


A Rare Presentation of Undifferentiated Pleomorphic Sarcoma in the Subpectoral Space.

Arthurs K, Suening B, Barrar E, Abbas H, Webb S Cureus. 2023; 15(8):e44482.

PMID: 37791158 PMC: 10544415. DOI: 10.7759/cureus.44482.


References
1.
Hsu H, Huang E, Wang C . Treatment results and prognostic factors in patients with malignant fibrous histiocytoma. Acta Oncol. 2004; 43(6):530-5. DOI: 10.1080/02841860410018421. View

2.
Hu C, Pan Z, Yang J, Chu X, Zhang J, Tao X . Nomograms for predicting long-term overall survival and cancer-specific survival in lip squamous cell carcinoma: A population-based study. Cancer Med. 2019; 8(8):4032-4042. PMC: 6639254. DOI: 10.1002/cam4.2260. View

3.
KEARNEY M, Soule E, IVINS J . Malignant fibrous histiocytoma: a retrospective study of 167 cases. Cancer. 1980; 45(1):167-78. DOI: 10.1002/1097-0142(19800101)45:1<167::aid-cncr2820450127>3.0.co;2-8. View

4.
Shen W, Sakamoto N, Yang L . Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis. BMC Cancer. 2016; 16:413. PMC: 4936003. DOI: 10.1186/s12885-016-2438-3. View

5.
Sun W, Cheng M, Zhou H, Huang W, Qiu Z . Nomogram Predicting Cause-Specific Mortality in Nonmetastatic Male Breast Cancer: A Competing Risk Analysis. J Cancer. 2019; 10(3):583-593. PMC: 6360428. DOI: 10.7150/jca.28991. View